Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert W. Clarke is active.

Publication


Featured researches published by Robert W. Clarke.


Drug Discovery Today | 2006

Airborne infectious disease and the suppression of pulmonary bioaerosols.

Jennifer Fiegel; Robert W. Clarke; David A. Edwards

n n The current understanding of airborne pathogen spread in relation to the new methods of suppressing exhaled bioaerosols using safe surface-active materials, such as isotonic saline, is reviewed here. We discuss the physics of bioaerosol generation in the lungs, what is currently known about the relationship between expired bioaerosols and airborne infectious disease and current methods of airborne infectious disease containment. We conclude by reviewing recent experiments that suggest the delivery of isotonic saline can significantly diminish exhaled aerosol – generated from airway lining fluid in the course of natural breathing. We also discuss these implications in relation to airborne infectious disease control.n n


Pulmonary Pharmacology & Therapeutics | 2018

Inhaled calcium salts inhibit tobacco smoke-induced inflammation by modulating expression of chemokines and cytokines

Paulette W. Andreotta; Steve Arold; Jennifer Kenyon; Diane Spicer; Paul Woodman; Elizabeth Berry; Tim Brogan; Sophanna Kong; Pamela Okerholm; Vince Russell; Robert W. Clarke; David L. Hava

Tobacco smoke-induced lung inflammation in patients with chronic obstructive pulmonary disease (COPD) worsens with disease progression and acute exacerbations caused by respiratory infections. Chronic therapies to manage COPD center on bronchodilators to improve lung function and inhaled corticosteroids (ICS) to help reduce the risk of exacerbations. Novel therapies are needed that reduce the underlying inflammation associated with COPD and the inflammation resulting from respiratory infections that worsen disease. The lung is lined with airway surface liquid (ASL), a rheologically active material that provides an innate defense for the airway against inhaled particulate and is continuously cleared from the airways by mucociliary clearance. The rheological properties of the ASL can be altered by changes in airway hydration and by cations, such as calcium, that interact with electronegative glycoproteins. The effect of inhaled salts on inflammation resulting from tobacco smoke exposure was studied to determine if cations could be used to alter the properties of the ASL and reduce inflammation. Inhaled calcium salts, but not sodium or magnesium salts, reduced cellular inflammation and key chemokines and cytokines that were induced by tobacco smoke exposure. Similar anti-inflammatory effects of calcium salts were observed using in vitro cultures of human monocyte derived macrophages and human bronchial epithelial cells. The data suggest that inhaled calcium salts may act broadly on both biophysical and biological pathways to reduce pulmonary inflammation.


Archive | 2007

Method and device for decreasing contamination

David A. Edwards; Mark J. Gabrielson; Robert W. Clarke; Wesley H. Dehaan; Matthew Brande; Jonathan Man


Archive | 2010

Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis

Robert W. Clarke; Richard P. Batycky; Wesley H. Dehaan; David L. Hava; Michael M. Lipp; John Hanrahan


Journal of Colloid and Interface Science | 2007

Why inhaling salt water changes what we exhale

Wiwik Watanabe; Matthew Thomas; Robert W. Clarke; Alexander M. Klibanov; Robert Langer; Jeffrey P. Katstra; Gerald G. Fuller; L.C. Griel; Jennifer Fiegel; David A. Edwards


Archive | 2006

Formulations for alteration of biophysical properties of mucosal lining

Wiwik Watanabe; Matthew Thomas; Jeffrey P. Katstra; Robert W. Clarke


Archive | 2012

Methods for treating and diagnosing respiratory tract infections

Robert W. Clarke; David L. Hava; John Hanrahan; Wesley H. Dehaan; Paulette W. Andreotta; Stephen P. Arold; Jennifer Kenyon


Archive | 2010

Pharmaceutical formulations and methods for treating respiratory tract infections

Michael M. Lipp; Robert W. Clarke; David L. Hava; Richard P. Batycky; John Hanrahan


Archive | 2007

Formulations decreasing particle exhalation

David A. Edwards; Jonathan Man; Jeffrey P. Katstra; Robert W. Clarke


Archive | 2010

CALCIUM CITRATE AND CALCIUM LACTATE FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING

Robert W. Clarke; Richard P. Batycky; David L. Hava; Michal M. Lipp

Collaboration


Dive into the Robert W. Clarke's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L.C. Griel

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Wiwik Watanabe

VTT Technical Research Centre of Finland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge